Maternal exposure to δ9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central μ opioid receptors in adult offspring female rats

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 101-109

  Vela, Gema ^a   Martín, Sonsoles ^b   García Gil, Lucía ^c   Crespo, José Antonio ^b   Ruiz Gayo, Mariano ^a   Javier Fernández Ruiz, José ^c   García Lecumberri, Carmen ^d   Pélaprat, Didier ^e   Fuentes, José Angel ^a   Ramos, José Antonio ^c   Ambrosio, Emilio ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Department of Electrical Engineering   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

9 Tetrahydrocannabinol; Cannabinoid; Drug addiction; Intravenous morphine self administration; Opiate; Opioid neuron; Opioid receptor; Perinatal exposure; Reinforcement

Indexed keywords

CANNABIS; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; DATA ANALYSIS; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; FACILITATION; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PUTAMEN; RAT; REINFORCEMENT; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; DRUG SELF ADMINISTRATION; FEEDING BEHAVIOR; FEMALE; INSTRUMENTAL CONDITIONING; MALE; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; CONDITIONING, OPERANT; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; FEEDING BEHAVIOR; FEMALE; MALE; MORPHINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TETRAHYDROCANNABINOL;

EID: 0032487221     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00766-5     Document Type: Article

References (50)

1. Ambrosio E., Goldberg S.R., Elmer G.I. Behavior genetic investigation of the relationship between spontaneous locomotor activity and the acquisition of morphine self-administration behavior. Behav. Pharmacol. 6:1995;229-237.
2. Berridge K.C. Food reward: brain substrates of wanting and liking. Neurosci. Biobehav. rev. 20:1996;1-25.
3. Bonnin A., de Miguel R., Rodríguez-Manzaneque J.C., Fernández-Ruiz J.J., Santos A., Ramos J.A. Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Dev. Brain Res. 81:1994;147-150.
4. 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 56:1995;2177-2184.
5. 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. Mol. Neurosci. 7:1996;291-308.
6. Caboche J., Rogard M., Besson M.J. Comparative development of D1-dopamine and μ-opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate μ but not D1 receptor distribution. Dev. Brain Res. 58:1991;111-122.
7. Dalterio S.L. Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice. Pharmacol. Biochem. Behav. 12:1980;143-153.
8. Dalterio S.L. Cannabinoid exposure: effects on development. Neurobehav. Toxicol. Teratol. 8:1986;345-352.
9. De Vries T.J., Hogenboom F., Mulder A.H., Schoffelmeer A.N.M. Ontogeny of μ-, δ- and κ-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. Dev. Brain Res. 54:1990;63-69.
10. Ettenberg A., Pettit H.O., Bloom F.E., Koob G.F. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology. 78:1982;204-209.
11. J.J. Fernández-Ruiz, F. Rodríguez de Fonseca, M. Navarro, J.A. Ramos, Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopaminergic neurons, in: A. Bartke, L.L. Murphy, (Eds.), Neurobiology and Neurophysiology of Cannabinoids, Biochemistry and Physiology of Substance Abuse, Vol. IV, CRC Press, Boca Raton, FL, 1992, pp. 119-164.
12. J.J. Fernández-Ruiz, A. Bonnin, M. Cebeira, J.A. Ramos, Ontogenic and adult changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure, in: T. Palomo, T. Archer (Eds.), Strategies for Studying Brain Disorders, Vol. 1., Farrand Press, England, 1994, pp. 357-390.
13. J.J. Fernández-Ruiz, J. Romero, L. García-Gil, E. García-Palomero, J.A. Ramos, Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana: developmental and adult studies, in: R.J. Beninger, T. Archer, T. Palomo (Eds.), Dopamine Disease States, CYM Press, Madrid, Spain, 1996, pp. 359-387.
14. 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug Alcohol Depend. 42:1996;155-166.
15. Goeders N.E., Guerin G.F. Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 64:1996;337-348.
16. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
17. S. Kaymakcalan, Pharmacological similarities and interactions between cannabinoids and opioids, in: G.G. Nahas, W.D.M. Paton (Eds.), Marihuana: Biological Effects, Pergamon Press, New York, 1979, pp. 591-604.
18. Keller R.W. Jr., LeFreve R., Raucci J., Carlson J.N., Glick S.D. Enhanced cocaine self-administration in adult rats prenatally exposed to cocaine. Neurosci. Lett. 205:1996;153-156.
19. Kelley B.M., Middaugh L.D. Ethanol self-administration and motor deficits in adult C57BL/6J mice exposed prenatally to cocaine. Pharmacol. Biochem. Behav. 55:1996;575-584.
20. 9-tetrahydrocannabinol influences neuroendocrine and reproductive functions in female rats. Neuroendocrinology. 44:1986;260-264.
21. 9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain. Brain Res. 525:1990;78-83.
22. Lacey M.G., Mercuri N.B., North R.A. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J. Neurosci. 9:1989;1233-1241.
23. 9-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behav. Pharmacol. 5:1994;219-225.
24. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic distribution of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
25. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking μ-opioid-receptor gene. Nature. 383:1996;819-823.
26. 9-tetrahydrocannabinol alters the neurochemical response to stress in the adult Fischer-344 rat. Neurotoxicol. Teratol. 9:1987;321-326.
27. G.G. Nahas, Toxicology and Pharmacology, in: G.G. Nahas (Ed.), Marihuana in Science and Medicine, Raven Press, New York, 1984, pp. 102-247.
28. Navarro M., Rodríguez de Fonseca F., Hernández M.L., Ramos J.A., Fernández-Ruiz J.J. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 47:1994;47-58.
29. Navarro M., de Miguel R., Rodríguez de Fonseca F., Ramos J.A., Fernández-Ruiz J.J. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 75:1996;91-98.
30. 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo dialysis study. Brain Res. 451:1988;59-68.
31. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, 1986.
32. Pettit H.O., Ettenberg A., Bloom F.E., Koob G.F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but heroin self-administration in rats. Psychopharmacology. 84:1984;167-173.
33. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
34. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. PNAS (USA). 88:1991;2088-2092.
35. Rodríguez de Fonseca F., Cebeira M., Fernández-Ruiz J.J., Navarro M., Ramos J.A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43:1991;713-723.
36. Rodríguez de Fonseca F., Hernández M.L., de Miguel R., Fernández-Ruiz J.J., Ramos J.A. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids. Pharmacol. Biochem. Behav. 41:1992;469-474.
37. Rodríguez de Fonseca F., Cebeira M., Ramos J.A., Martín M., Fernández-Ruiz J.J. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci. 54:1994;159-170.
38. 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis. Life Sci. 56:1995;2169-2176.
39. Schenk K.S., Valadez A., Horger B.A., Snow S., Wellman P.J. Interactions between caffeine and cocaine in tests of self-administration. Behav. Pharmacol. 5:1994;153-158.
40. 9-tetrahydrocannabinol and kappa opioids in mice. J. Pharmacol. Exp. Ther. 268:1994;1381-1387.
41. N.R. Swerdlow, D. Gilbert, G.F. Koob, Conditioned drug effects on spatial preference: critical evaluation, in: A.A. Boulton, G.B. Baker, A.J. Greenshow (Eds.), Psychopharmacology. Neuromethods, Vol. 13, Humana Press, Clifton, NJ, 1989, pp. 399-446.
42. Trovero F., Hervé D., Desban M., Glowinski J., Tassin J.P. Striatal opiate μ receptors are not located on dopamine nerve endings in the rat. Neuroscience. 39:1990;313-321.
43. 9-tetrahydrocannabinol in rats. Eur. J. Pharmacol. 70:1981;219-224.
44. Vaysse P.J., Gardner E.L., Zukin R.S. Modulation of rat brain opioid receptors by cannabinoids. J. Pharmacol. Exp. Ther. 241:1987;534-539.
45. 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res. 680:1995;142-147.
46. Walters D.E., Carr L.A. Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol. Biochem. Behav. 25:1986;763-778.
47. Walters D.E., Carr L.A. Perinatal exposure to cannabinoids alters neurochemical development in the rat brain. Pharmacol. Biochem. Behav. 29:1988;213-216.
48. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine in mice. J. Pharmacol. Exp. Ther. 262:1992;10-18.
49. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
50. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.